{
    "id": "35cd5b23-b99c-d38f-e063-6294a90a294d",
    "indications": "levocetirizine dihydrochloride histamine h 1 -receptor antagonist indicated : relief symptoms associated perennial allergic rhinitis ( 1.1 ) treatment uncomplicated skin manifestations chronic idiopathic urticaria ( 1.2 )",
    "contraindications": "levocetirizine dihydrochloride available 2.5 mg/5 ml ( 0.5 mg/ml ) oral solution 5 mg breakable ( scored ) tablets , allowing 2.5 mg , needed . levocetirizine dihydrochloride taken without regard food consumption .",
    "warningsAndPrecautions": "levocetirizine dihydrochloride tablets white off-white , film-coated , scored , oval , biconvex , debossed `` l9cz 5 `` unscored side nothing scored side , contain 5 mg levocetirizine dihydrochloride . supplied following hdpe bottle configurations : 30 tablets ( ndc 63672-0051-1 ) 90 tablets ( ndc 63672-0051-2 ) 300 tablets ( ndc 63672-0051-3 ) storage : store 20 25°c ( 68 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] .",
    "adverseReactions": "levocetirizine dihydrochloride contraindicated :",
    "ingredients": [
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "LEVOCETIRIZINE DIHYDROCHLORIDE",
            "code": "SOD6A38AGA"
        }
    ],
    "organization": "Synthon Pharmaceuticals, Inc.",
    "name": "Levocetirizine dihydrochloride",
    "effectiveTime": "20250527",
    "indications_original": "Levocetirizine dihydrochloride is a histamine H 1 -receptor antagonist indicated for: The relief of symptoms associated with perennial allergic rhinitis ( 1.1 ) The treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria ( 1.2 )",
    "contraindications_original": "Levocetirizine dihydrochloride is available as 2.5 mg/5 mL (0.5 mg/mL) oral solution and as 5 mg breakable (scored) tablets, allowing for the administration of 2.5 mg, if needed. Levocetirizine dihydrochloride can be taken without regard to food consumption.",
    "warningsAndPrecautions_original": "Levocetirizine dihydrochloride tablets are white to off-white, film-coated, scored, oval, biconvex, debossed with \"L9CZ 5\" on the unscored side and nothing on the scored side, and contain 5 mg levocetirizine dihydrochloride. They are supplied in the following HDPE bottle configurations:\n                  30 Tablets (NDC 63672-0051-1) \n    90 Tablets (NDC 63672-0051-2) \n    300 Tablets (NDC 63672-0051-3)\n \n                  \n                     Storage:\n                  \n                  Store at 20 to 25°C (68 to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "The use of levocetirizine dihydrochloride is contraindicated in:"
}